U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359599) titled 'The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension' on Jan. 09.
Brief Summary: Pulmonary hypertension (PH) is a condition characterized by elevated blood pressure in the pulmonary arteries. This leads to symptoms such as shortness of breath and a significantly reduced exercise capacity, resulting in a very poor quality of life. Currently, treatment options for PH are limited.
More than 60% of patients with PH develop iron deficiency. Studies have shown that this deficiency is associated with more severe symptoms, reduced exercise capacity, and even lower quality of life. Oral iron supplements a...